Relmada Therapeutics (RLMD) Invested Capital (2014 - 2021)
Relmada Therapeutics' Invested Capital came in at $105.58 million for Q4 2020, down 8.8% from $115.79 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Invested Capital (2014 - 2021) Analysis & Trends
Going back to Q4 2014, Relmada Therapeutics' Invested Capital data covers 6 quarters.
- Invested Capital carries a five-year compound annual growth rate of 63.4% (FY2015 to FY2020).
- Going back by year, Invested Capital was $115.79 million in FY2019, -$2.29 million in FY2018, $1.74 million in FY2017 (-76.3%) and $7.32 million in FY2016 (-19.4%).
- The Q4 2020 figure represents the lowest quarterly Invested Capital since Q4 2014.
- Business Quant data shows RLMD's Invested Capital at $122.21 million (Q3 2020), $132.23 million (Q2 2020) and $113.16 million (Q1 2020) in the three quarters before Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 96.10 Mn |
| Jun 30, 2021 | 120.31 Mn |
| Dec 31, 2020 | 105.58 Mn |
| Sep 30, 2020 | 122.21 Mn |
| Jun 30, 2020 | 132.23 Mn |
| Mar 31, 2020 | 113.16 Mn |
| Dec 31, 2019 | 115.79 Mn |
| Sep 30, 2019 | 6.23 Mn |
| Jun 30, 2019 | 7.98 Mn |
| Mar 31, 2019 | 502,698.00 |
| Dec 31, 2018 | 1.55 Mn |
| Sep 30, 2018 | -5.09 Mn |
| Jun 30, 2018 | -2.29 Mn |
| Mar 31, 2018 | -683,933.00 |
| Dec 31, 2017 | 2.22 Mn |
| Sep 30, 2017 | 3.21 Mn |
| Jun 30, 2017 | 1.74 Mn |
| Mar 31, 2017 | 2.83 Mn |
| Dec 31, 2016 | 4.79 Mn |
| Sep 30, 2016 | 5.74 Mn |
API Access
Relmada Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();